“New Merck” Reports First Year Of Schering-Plough-Busted-Up Results, This Thursday Morning

Of course I’ll live blog it — will there be an actual, rather than rumored settlement of the Centocor/J&J $10 billion arbitration to report, by then?

Will currencies have dampened full-year sales by more than 4 percent?

Will CEO Frazier be ready to announce an intention to wholly-exit the Consumer Health businesses [as his counterpart at the (no relation) German Merck just did]?

We shall see. The some 20 analysts covering Merck (per Yahoo! Biz), on average, expect non-GAAP 2010 EPS of $3.38, on sales of $45.48 billion.

The company itself last said (on pain of SEC liability) that it “expected full year 2010 non-GAAP EPS to be between $3.27 and $3.41, excluding certain items and a 2010 GAAP EPS range of $1.15 to $1.50.” Do stop back:

. . . .Q4 2010 Merck & Co., Inc. Earnings Conference Call

Thursday, February 3, 2011 8:00 a.m. ET

Click here to listen with Windows Media. . . .


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s